CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients.
| Autor: | Gallegos-Arreola MP; Molecular Genetics Laboratory, Division of Molecular Medicine, Centro de Investigacin Biomdica de Oc., Figuera-Villanueva LE, Troyo-Sanroman R, Morgn-Villela G, Puebla-Prez AM, Flores-Marquez MR, Zniga-Gonzlez GM |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The International journal of biological markers [Int J Biol Markers] 2008 Jan - Mar; Vol. 23 (1), pp. 24-30. |
| DOI: | 10.5301/JBM.2008.379 |
| Abstrakt: | Background: CYP1A1 is a gene involved in the high aryl hydrocarbon hydroxylase -inducible phenotype, which is a genetically-determined variation among individuals that has been associated with lung cancer risk. More specifically, CYP1A1*2B and *4 polymorphisms have been associated with high susceptibility to lung cancer among cigarette smokers. Materials and Methods: DNA was obtained from blood samples and we studied by PCR-RFLP the distribution of CYP1A1*2B (n=248) and *4 (n=222) polymorphisms in healthy controls and 222 lung cancer patients from a Mexican population. Results: Comparisons between groups showed an increased risk for lung cancer patients of *2B/*2B (18%; OR 7.6; 95% CI 3.0-19.2) and *4/*4 genotypes (15%; OR 11.45; 95% CI 2.19-59.85) compared to the control group (1% for *2B/*2B and 4.4% for *4/*4). A significant association between lung cancer and homozygous *2B/*2B passive smokers and *4/*4 ever (cigarettes) and passive smokers was also observed (p<0.05). Multivariate analysis revealed an increased risk for the *2B/2B genotype (OR 6.83), as well as for *4/*4 (OR 28.8). Conclusion: The results of the study indicate a significant association between *2B/*2B and *4/*4 genotypes and the risk of developing lung cancer among Mexicans. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|